Ghai Jyotsna 4
4 · Singular Genomics Systems, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Ghai Jyotsna
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2025-01-02+417→ 3,033 total - Exercise/Conversion
Restricted Stock Units
2025-01-02−417→ 4,583 total→ Common Stock (417 underlying)
Footnotes (4)
- [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]Includes 100 shares acquired under the Issuer's employee stock purchase plan since the Reporting Person last filed a Form 4 with the Securities and Exchange Commission.
- [F3]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F4]25% of the RSUs vested on October 2, 2024; the remainder of the RSUs vest in 12 equal quarterly installments thereafter, beginning on January 2, 2025.